PE20150354A1 - Metodos para preparar triazolopiridinas sustituidas - Google Patents

Metodos para preparar triazolopiridinas sustituidas

Info

Publication number
PE20150354A1
PE20150354A1 PE2015000017A PE2015000017A PE20150354A1 PE 20150354 A1 PE20150354 A1 PE 20150354A1 PE 2015000017 A PE2015000017 A PE 2015000017A PE 2015000017 A PE2015000017 A PE 2015000017A PE 20150354 A1 PE20150354 A1 PE 20150354A1
Authority
PE
Peru
Prior art keywords
phenyl
triazolopyridines
methods
compounds
propanamide
Prior art date
Application number
PE2015000017A
Other languages
English (en)
Spanish (es)
Inventor
Volker Schulze
Franz-Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of PE20150354A1 publication Critical patent/PE20150354A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE2015000017A 2012-07-10 2013-07-03 Metodos para preparar triazolopiridinas sustituidas PE20150354A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05

Publications (1)

Publication Number Publication Date
PE20150354A1 true PE20150354A1 (es) 2015-03-21

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000017A PE20150354A1 (es) 2012-07-10 2013-07-03 Metodos para preparar triazolopiridinas sustituidas

Country Status (24)

Country Link
US (1) US9388177B2 (show.php)
EP (1) EP2872506A1 (show.php)
JP (1) JP6238979B2 (show.php)
KR (1) KR20150040845A (show.php)
CN (1) CN104603136B (show.php)
AP (1) AP3778A (show.php)
AU (1) AU2013289381A1 (show.php)
BR (1) BR112015000308A2 (show.php)
CA (1) CA2878481A1 (show.php)
CL (1) CL2015000038A1 (show.php)
CO (1) CO7160002A2 (show.php)
CR (1) CR20150006A (show.php)
DO (1) DOP2015000007A (show.php)
EA (1) EA027544B1 (show.php)
HK (1) HK1206731A1 (show.php)
IL (1) IL236265A (show.php)
IN (1) IN2015DN00085A (show.php)
MX (1) MX2015000348A (show.php)
NZ (1) NZ703020A (show.php)
PE (1) PE20150354A1 (show.php)
PH (1) PH12015500061A1 (show.php)
SG (1) SG11201408419QA (show.php)
TN (1) TN2015000008A1 (show.php)
WO (1) WO2014009219A1 (show.php)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016527193A (ja) * 2013-06-07 2016-09-08 バイエル・ファルマ・アクティエンゲゼルシャフト 置換トリアゾロピリジン
US20160128988A1 (en) 2013-06-11 2016-05-12 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
AP2015008898A0 (en) * 2013-06-11 2015-12-31 Bayer Pharma AG Prodrug derivatives of substituted triazolopyridines
JP6993233B2 (ja) 2015-04-17 2022-01-13 ネザーランズ トランスレーショナル リサーチ センター ビー.ブイ. Ttk阻害剤化学療法の為の予後バイオマーカー
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030937A1 (en) * 2001-10-05 2003-04-17 Ono Pharmaceutical Co., Ltd. Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
JP2007537296A (ja) * 2004-05-14 2007-12-20 アボット・ラボラトリーズ 治療薬としてのキナーゼ阻害薬
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
MX2007004179A (es) * 2004-10-07 2007-06-07 Warner Lambert Co Derivados de triazolpiridina como agentes antibacterianos.
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
TW200808802A (en) * 2006-06-06 2008-02-16 Schering Corp Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
BRPI0716239A2 (pt) 2006-08-30 2013-08-13 Cellzome Ltd derivados de triazol como inibidores de cinase
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
MX2010000716A (es) 2007-07-18 2010-03-26 Novartis Ag Compuestos de heteroarilo biciclicos y su uso como inhibidores de cinasa.
BRPI0815709A2 (pt) 2007-08-23 2017-06-13 Astrazeneca Ab composro, composição farmacêutica, e, uso de um composto.
EP2181112A1 (en) 2007-08-31 2010-05-05 Merck Serono S.A. Triazolopyridine compounds and their use as ask inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009137322A2 (en) * 2008-05-05 2009-11-12 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
EP2303890A4 (en) * 2008-06-19 2012-04-11 Progenics Pharm Inc INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
US20120041195A1 (en) 2009-02-13 2012-02-16 Fovea Pharmaceuticals Heterocyclic compounds
WO2010124826A1 (en) 2009-04-29 2010-11-04 Bayer Schering Pharma Aktiengesellschaft Substituted imidazoquinoxalines
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
CN102459258B (zh) * 2009-06-05 2015-11-25 赛福伦公司 1,2,4-三唑并[1,5a]吡啶衍生物的制备和用途
US9340528B2 (en) 2009-09-04 2016-05-17 Bayer Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343295A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
SI2699575T1 (sl) 2011-04-21 2015-10-30 Bayer Intellectual Property Gmbh Triazolopiridini
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
CR20150006A (es) 2015-02-16
US20150148542A1 (en) 2015-05-28
PH12015500061A1 (en) 2015-03-02
MX2015000348A (es) 2015-04-14
JP2015523372A (ja) 2015-08-13
CO7160002A2 (es) 2015-01-15
TN2015000008A1 (en) 2016-06-29
EA027544B1 (ru) 2017-08-31
IN2015DN00085A (show.php) 2015-05-29
CN104603136A (zh) 2015-05-06
JP6238979B2 (ja) 2017-11-29
AP2014008177A0 (en) 2014-12-31
KR20150040845A (ko) 2015-04-15
AP3778A (en) 2016-08-31
EA201590116A1 (ru) 2015-07-30
SG11201408419QA (en) 2015-01-29
HK1206731A1 (en) 2016-01-15
NZ703020A (en) 2017-08-25
US9388177B2 (en) 2016-07-12
CN104603136B (zh) 2017-06-27
AU2013289381A1 (en) 2015-01-22
CA2878481A1 (en) 2014-01-16
BR112015000308A2 (pt) 2017-06-27
CL2015000038A1 (es) 2015-03-13
WO2014009219A1 (en) 2014-01-16
EP2872506A1 (en) 2015-05-20
DOP2015000007A (es) 2015-02-15
IL236265A (en) 2017-07-31
IL236265A0 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
EA201390199A1 (ru) 2-замещенные-8-алкил-7-оксо-7,8-дигидропиридо[2,3-d]пиримидин-6-карбонитрилы и их применение
CL2014000746A1 (es) Compuestos derivados de 3-pirimidin-4-il-oxazolidin-2-ona y sus sales, como inhibidores de las proteinas idh mutantes; composicion farmaceutica que los comprende, utiles para el tratamiento de trastornos de la proliferacion celular tal como el cancer.
UY33985A (es) Sales de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida
UY32863A (es) COMPUESTOS DE HEXAHIDROOXAZINOPTERINA PARA USO COMO INHIBIDORES DE mTOR
AR094204A1 (es) Composiciones para el cuidado oral que contienen haluros de acido amino
UY34104A (es) ?compuestos derivados benzamídicos heterocíclicos, procesos e intermedios para su preparación, composiciones y métodos para su uso?.
ECSP14013215A (es) Compuestos novedosos
UY33337A (es) DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
CU20140110A7 (es) Compuestos heterocíclicos como inhibidores de mek
CR20130550A (es) Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina
UY34301A (es) COMPUESTOS Y COMPOSICIONES COMO INHIBIDORES DE LA QUINASA c-Kit
CR20130349A (es) COMPUESTOS SUSTITUIDOS DE N-(1H- INDAZOL-4-IL) IMIDAZO [1,2-a] PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA TIROSINA QUINASA RECEPTORA DE TIPO III
UY34037A (es) Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
UY33943A (es) Derivados espirocíclicos de isoxazolina como agentes antiparasitarios.
UY4149Q (es) Golosina para mascota
CO6680607A2 (es) Métodos para la preparación de profármacos de fosforamidato diastereoméricamente puros
UY35241A (es) Compuestos antivirales
CO6531496A2 (es) Amidas sustituidas con halógenoalquilo como insecticidas y acaricidas
CU24045B1 (es) Aril piridinas como inhibidoras de sintasa de aldosterona
CR20140204A (es) Métodos para preparar análogos nucleotídicos antivirales
PE20150354A1 (es) Metodos para preparar triazolopiridinas sustituidas
CO6801757A2 (es) Derivados de pirazolo pirocetona para usarse como inhibidores de la acetil coa carboxilasa
NI201600014A (es) Compuestos y composiciones como inhibidores de la mek.
UY33888A (es) Derivados de (1,2,4) triazolo [4,3-a) quinoxalina como inhibidores de fosfodiesterasas
UY4148Q (es) Golosina para mascota

Legal Events

Date Code Title Description
FD Application declared void or lapsed